L. Robinson, E. Tang, and J. P. Taylor, Dementia: timely diagnosis and early intervention, vol.350, p.3029, 2015.

G. Livingston, A. Sommerlad, V. Orgeta, S. G. Costafreda, J. Huntley et al., Dementia prevention, intervention, and care, Lancet, vol.390, pp.2673-2734, 2017.

C. Patterson, Alzheimer's Disease International (ADI), World Alzheimer Report, 2018.

J. Ryan, P. Fransquet, J. Wrigglesworth, and P. Lacaze, Phenotypic Heterogeneity in Dementia: A Challenge for Epidemiology and Biomarker Studies, Frontiers in Public Health, vol.6, 2018.

S. E. O'bryant, M. M. Mielke, R. A. Rissman, S. Lista, H. Vanderstichele et al., Bloodbased biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic, Alzheimers Dement, vol.13, pp.45-58, 2017.

M. François, W. Leifert, R. Martins, P. Thomas, and M. Fenech, Biomarkers of Alzheimer's disease risk in peripheral tissues; focus on buccal cells, Current Alzheimer research, vol.11, pp.519-531, 2014.

C. R. Jack, D. S. Knopman, W. J. Jagust, R. C. Petersen, M. W. Weiner et al., Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers, The Lancet. Neurology, vol.12, pp.207-216, 2013.

G. B. Andersen and J. Tost, A Summary of the Biological Processes, Disease-Associated Changes, and Clinical Applications of DNA Methylation, Methods Mol Biol, vol.1708, pp.3-30, 2018.

C. Fenoglio, E. Scarpini, M. Serpente, and D. Galimberti, Role of Genetics and Epigenetics in the Pathogenesis of Alzheimer's Disease and Frontotemporal Dementia, J Alzheimers Dis, vol.62, pp.913-932, 2018.

E. Li and Y. Zhang, DNA methylation in mammals. Cold Spring Harbor perspectives in biology 6, p.19133, 2014.

R. C. Slieker, C. L. Relton, T. R. Gaunt, and P. E. Slagboom, Age-related DNA methylation changes are tissue-specific with ELOVL2 promoter methylation as exception, Epigenetics & Chromatin, vol.11, p.25, 2018.

R. Delgado-morales and M. Esteller, Opening up the DNA methylome of dementia, Mol Psychiatry, vol.22, pp.485-496, 2017.

E. Hannon, K. Lunnon, L. Schalkwyk, and J. Mill, Interindividual methylomic variation across blood, cortex, and cerebellum: implications for epigenetic studies of neurological and neuropsychiatric phenotypes, Epigenetics, vol.10, pp.1024-1032, 2015.

P. R. Braun, S. Han, B. Hing, Y. Nagahama, L. N. Gaul et al., Genome-wide DNA methylation comparison between live human brain and peripheral tissues within individuals, Translational Psychiatry, vol.9, p.47, 2019.

P. D. Fransquet, P. Lacaze, R. Saffery, J. Mcneil, R. Woods et al., Blood DNA methylation as a potential biomarker of dementia: A systematic review, Alzheimers Dement, vol.14, pp.81-103, 2018.

B. Lima-giacobbo, J. Doorduin, H. C. Klein, R. Dierckx, E. Bromberg et al., Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation, Mol Neurobiol, vol.56, pp.3295-3312, 2019.

J. H. Song, J. T. Yu, and L. Tan, Brain-Derived Neurotrophic Factor in Alzheimer's Disease: Risk, Mechanisms, and Therapy, Mol Neurobiol, vol.52, pp.1477-1493, 2015.

C. A. Lane, J. Hardy, and J. M. Schott, Alzheimer's disease, Eur J Neurol, vol.25, pp.59-70, 2018.

T. Ng, C. Ho, W. Tam, E. H. Kua, and R. C. Ho, Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis, Int J Mol Sci, vol.20, p.257, 2019.

L. Chang, Y. Wang, H. Ji, D. Dai, X. Xu et al., Elevation of peripheral BDNF promoter methylation links to the risk of Alzheimer's disease, PLoS One, vol.9, 2014.

T. Nagata, N. Kobayashi, J. Ishii, S. Shinagawa, R. Nakayama et al., Association between DNA Methylation of the BDNF Promoter Region and Clinical Presentation in Alzheimer's Disease, Dement Geriatr Cogn Dis Extra, vol.5, pp.64-73, 2015.

L. Carboni, F. Lattanzio, S. Candeletti, E. Porcellini, E. Raschi et al., Peripheral leukocyte expression of the potential biomarker proteins Bdnf, Sirt1, and Psen1 is not regulated by promoter methylation in Alzheimer's disease patients, Neurosci Lett, vol.605, pp.44-48, 2015.

V. A. Fisher, L. Wang, X. Deng, C. Sarnowski, L. A. Cupples et al., Do changes in DNA methylation mediate or interact with SNP variation? A pharmacoepigenetic analysis, BMC genetics, vol.19, p.70, 2018.

Y. Y. Lim, S. Rainey-smith, Y. Lim, S. M. Laws, V. Gupta et al., BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF, Int Psychogeriatr, vol.29, pp.1825-1834, 2017.

T. Shen, Y. You, C. Joseph, M. Mirzaei, A. Klistorner et al., BDNF Polymorphism: A Review of Its Diagnostic and Clinical Relevance in Neurodegenerative Disorders, Aging and disease, vol.9, pp.523-536, 2018.

N. Franzmeier, J. Ren, A. Damm, G. Monte-rubio, M. Boada et al., The BDNF Val66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease, 2019.

B. C. Riedel, P. M. Thompson, and R. D. Brinton, Age, APOE and sex: Triad of risk of Alzheimer's disease, The Journal of steroid biochemistry and molecular biology, vol.160, pp.134-147, 2016.

C. H. Tan, B. T. Hyman, J. Tan, C. P. Hess, W. P. Dillon et al., Polygenic hazard scores in preclinical Alzheimer disease, Annals of neurology, vol.82, pp.484-488, 2017.

K. Ritchie, S. Artero, I. Beluche, M. L. Ancelin, A. Mann et al., Prevalence of DSM-IV psychiatric disorder in the French elderly population, Br J Psychiatry, vol.184, pp.147-152, 2004.

M. L. Ancelin, I. Carriere, J. Scali, K. Ritchie, I. Chaudieu et al., Angiotensin-converting enzyme gene variants are associated with both cortisol secretion and late-life depression, Transl Psychiatry, vol.3, p.322, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00914310

M. F. Folstein, S. E. Folstein, and P. R. Mchugh, A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, vol.12, pp.189-198, 1975.

A. L. Benton and A. B. Silvan, Benton Visual Retention Test -Fifth Edition, 1992.

B. Isaacs and A. T. Kennie, The Set test as an aid to the detection of dementia in old people, Br J Psychiatry, vol.123, pp.467-470, 1973.

J. D. Corrigan and N. S. Hinkeldey, Relationships between parts A and B of the Trail Making Test, J Clin Psychol, vol.43, pp.402-409, 1987.

, Diagnostic and statistical manual of mental disorders, 1994.

M. B. First, A. Frances, and H. A. Pincus, DSM-IV-TR handbook of differential diagnosis, 2002.

V. Januar, M. L. Ancelin, K. Ritchie, R. Saffery, and J. Ryan, BDNF promoter methylation and genetic variation in late-life depression, Transl Psychiatry, vol.5, p.619, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02398352

A. T. Beekman, D. J. Deeg, J. Van-limbeek, A. W. Braam, D. Vries et al., Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in The Netherlands, Psychol Med, vol.27, pp.231-235, 1997.

K. Ritchie, I. Jaussent, R. Stewart, A. Dupuy, P. Courtet et al., Association of adverse childhood environment and 5-HTTLPR Genotype with late-life depression, The Journal of clinical psychiatry, vol.70, pp.1281-1288, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00325784

R. Saffery and L. Gordon, Time for a standardized system of reporting sites of genomic methylation, Genome biology, vol.16, p.85, 2015.

M. Raitio, R. Harinen, and J. Lampinen, Validation of KASPar? Dual FRET Based SNP Genotyping Assay, pp.1-5, 2012.

J. Ryan, I. Carriere, L. Carcaillon, J. F. Dartigues, S. Auriacombe et al., Estrogen receptor polymorphisms and incident dementia: the prospective 3C study, Alzheimers Dement, vol.10, pp.27-35, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-00828131

M. K. Andrew and M. C. Tierney, The puzzle of sex, gender and Alzheimer's disease: Why are women more often affected than men? Women's Health 14, p.1745506518817995, 2018.

D. R. Masser, N. Hadad, H. L. Porter, C. A. Mangold, A. Unnikrishnan et al., Sexually divergent DNA methylation patterns with hippocampal aging, Aging Cell, vol.16, pp.1342-1352, 2017.

T. Ngandu, V. Strauss, E. Helkala, E. L. Winblad, B. Nissinen et al., Education and dementia: what lies behind the association?, Neurology, vol.69, pp.1442-1450, 2007.

Y. M. Geurts, P. A. Dugue, J. E. Joo, E. Makalic, C. H. Jung et al., Novel associations between blood DNA methylation and body mass index in middle-aged and older adults, Int J Obes, vol.42, pp.887-896, 2018.

D. Chen, L. Meng, F. Pei, Y. Zheng, and J. Leng, A review of DNA methylation in depression, J Clin Neurosci, vol.43, pp.39-46, 2017.

A. Bansal and S. E. Pinney, DNA methylation and its role in the pathogenesis of diabetes, Pediatr Diabetes, vol.18, pp.167-177, 2017.

D. Lakens, Equivalence Tests: A Practical Primer for t Tests, Correlations, and Meta-Analyses, Soc Psychol Personal Sci, vol.8, pp.355-362, 2017.

Y. Benjamini and Y. Hochberg, Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing, Journal of the Royal Statistical Society. Series B (Methodological), vol.57, pp.289-300, 1995.

Y. Benjamini, R. Heller, and D. Yekutieli, Selective inference in complex research, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, vol.367, pp.4255-4271, 2009.

, World Health Organization (1993) The ICD-10 classification of mental and behavioural disorders, World Health Organization

G. Mckhann, D. Drachman, M. Folstein, R. Katzman, D. Price et al., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, vol.34, pp.939-944, 1984.

B. Reisberg, J. Borenstein, S. P. Salob, S. H. Ferris, E. Franssen et al., Behavioral symptoms in Alzheimer's disease: phenomenology and treatment, J Clin Psychiatry, vol.48, pp.9-15, 1987.

B. Dubois, A. Slachevsky, I. Litvan, and B. Pillon, The FAB: a Frontal Assessment Battery at bedside, Neurology, vol.55, pp.1621-1626, 2000.

P. D. Fransquet and J. Ryan, The current status of blood epigenetic biomarkers for dementia, Crit Rev Clin Lab Sci, vol.56, pp.435-457, 2019.

, The Joanna Briggs Institute. Joanna Briggs Institute Reviewers' Manual: 2016 edition. Australia: The, 2016.

S. K. Chu and H. C. Yang, Interethnic DNA methylation difference and its implications in pharmacoepigenetics, Epigenomics, vol.9, pp.1437-1454, 2017.

J. M. Galanter, C. R. Gignoux, S. S. Oh, D. Torgerson, M. Pino-yanes et al., Differential methylation between ethnic sub-groups reflects the effect of genetic ancestry and environmental exposures, p.20532, 2017.

S. Horvath, DNA methylation age of human tissues and cell types, Genome Biology, vol.14, p.3156, 2013.

C. Luo, P. Hajkova, and J. R. Ecker, Dynamic DNA methylation: In the right place at the right time, Science, vol.361, pp.1336-1340, 2018.

P. R. Braun, S. Han, B. Hing, Y. Nagahama, L. N. Gaul et al., Genome-wide DNA methylation comparison between live human brain and peripheral tissues within individuals, Translational psychiatry, vol.9, pp.47-47, 2019.

G. Ravaglia, P. Forti, F. Maioli, M. Martelli, L. Servadei et al., Conversion of mild cognitive impairment to dementia: predictive role of mild cognitive impairment subtypes and vascular risk factors, Dement Geriatr Cogn Disord, vol.21, pp.51-58, 2006.

B. Xie, Z. Liu, W. Liu, L. Jiang, R. Zhang et al., DNA Methylation and Tag SNPs of the BDNF Gene in Conversion of Amnestic Mild Cognitive Impairment into Alzheimer's Disease: A Cross-Sectional Cohort Study, J Alzheimers Dis, vol.58, pp.263-274, 2017.

B. Xie, Y. Xu, Z. Liu, W. Liu, L. Jiang et al., Elevation of Peripheral BDNF Promoter Methylation Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Longitudinal Study, J Alzheimers Dis, vol.56, pp.391-401, 2017.

G. Y. Zheleznyakova, H. Cao, and H. B. Schiöth, BDNF DNA methylation changes as a biomarker of psychiatric disorders: literature review and open access database analysis, Behavioral and brain functions, vol.12, p.17, 2016.

K. Lieb, N. Dreimüller, S. Wagner, K. Schlicht, T. Falter et al., BDNF Plasma Levels and BDNF Exon IV Promoter Methylation as Predictors for Antidepressant Treatment Response, Frontiers in Psychiatry, vol.9, p.511, 2018.

K. Na, E. Won, J. Kang, H. S. Chang, H. Yoon et al., Brain-derived neurotrophic factor promoter methylation and cortical thickness in recurrent major depressive disorder, Scientific Reports, vol.6, p.21089, 2016.

E. Hannon, K. Lunnon, L. Schalkwyk, and J. Mill, Blood Brain DNA Methylation Comparison Tool, issue.10, 2019.

, SUPPLEMENTART MATERIAL Is peripheral BDNF promoter methylation a preclinical biomarker of dementia?

D. Peter, K. Fransquet, V. Ritchie, R. Januar, M. Saffery et al., Joanne Ryan Table S1. Genomic Location of CpG's analysed for DNA methylation CpG Unit Genomic location (hg19) CpG, vol.744, p.252

, CpG 2 CpG11:27, vol.744, p.245

, CpG 6 CpG11:27, vol.744, p.210

, CpG 11.12 CpG11:27, vol.744, p.49